Gelesis Holdings, Inc. Banner Image

Gelesis Holdings, Inc.

  • Ticker GLS
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Gelesis Holdings, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis”) is a consumer-centered biotherapeutics company and the maker of Plenity®, which is inspired by nature and FDA cleared to aid in weight management. Their first-of-their-kind non-systemic superabsorbent hydrogels are made entirely from naturally derived building blocks. They are inspired by the composition and mechanical properties of raw vegetablesMore, taken by capsule, and act locally in the digestive system, so people feel satisfied with smaller portions. Their portfolio includes Plenity® and potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
3.0 / 5.0 (3)

Gelesis Holdings, Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Gelesis Holdings, Inc.

Most Recent Annual Report

Gelesis Holdings, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Gelesis Holdings, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!